EPA Proposes Adding Microplastics and Pharmaceuticals to Drinking Water Contaminant List for First Time

The Environmental Protection Agency has proposed including microplastics and pharmaceuticals on its Contaminant Candidate List for drinking water for the first time — a step that could eventually lead to new limits on these substances.

The Proposal

• Agency: EPA, led by Administrator Lee Zeldin
• List: Contaminant Candidate List (CCL) — 6th edition draft
• New additions: Microplastics and pharmaceuticals (first time)
• Comment period: 60 days, finalization by mid-November 2026

Why Now?

• Public concern: Growing worry about plastics in drinking water
• RFK Jr. influence: Aligns with MAHA (Make America Healthy Again) movement pressure on Zeldin
• Scientific evidence: Studies found microplastics in drinking water, human hearts, brains, and testicles

Scientific Context

Research has detected microplastics in:

• Drinking water (bottled and tap)
• Human hearts (cardiovascular patients)
• Human brains (post-mortem studies)
• Human testicles (reproductive health concerns)
• Blood (circulating nanoplastics)

Pharmaceutical Contamination

Conventional wastewater treatment fails to remove pharmaceutical drugs that humans excrete. These drugs enter the water supply, raising concerns about:

• Antibiotic resistance from trace antibiotics
• Hormonal disruption from birth control and other endocrine-active drugs
• Ecological impact on aquatic organisms

What Happens Next

The EPA uses the CCL to prioritize research, funding, and regulatory decisions. However, the agency has historically been slow to move from study to regulation — rarely setting enforceable limits for listed contaminants.